Assists clinicians about the probability of survival of kidney allograts after renal transplantation
A predictive tool to inform healthcare professionals about the probability of survival of kidney allografts after renal transplantation. These probabilities, along with all available standard clinical data, help to describe the status of the allograft and provide additional information in the decision about patient care and treatment. Specifically, Predigraft provides allograft survival probabilities at +3 / +5 / +7 years after evaluation, based on a combination of clinical, biological and histological parameters (iBox technology). In addition, it allows the transplant follow-up team to consolidate all patient follow-up information in one place to avoid loss of information and to improve data transmission between the various parties involved with the patient.
Apilife is also intended to be used as a remote monitoring tool after kidney transplantation to facilitate communication between the patient and their nephrologist by providing a system of customisable alerts. The patient can send clinical data such as weight and blood pressure, send documents such as biological analysis results or access the secure messaging system with the follow-up team. Finally, they have access to fun and comprehensive therapeutic education content.
EHR clinical data
App - Apilife, in the form of 'iBox alerts'
Claims to reduce manual entry of lab test data by 90%.
2,600 downloads of Apilife - evidence on RWE to be published publically
